Sort
46,585 grants matching “heart failure”
Pulmonary Mechanisms of Dyspnea in HFpEF: Impact of Obesity
$390,226Tony G Babb · Ut Southwestern Medical Center · P01 · FY2022 · HL
Premotor control of upper airway and REM sleep atonia
$390,225Leszek K Kubin · University Of Pennsylvania · R01 · FY2009 · HL
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)
$390,205John V Fahy · University Of California, San Francisco · UG1 · FY2018 · HL
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)
$390,202Ying Xian · Ut Southwestern Medical Center · R01 · FY2022 · AG
Cooperativity in the Cardiac Myofilament Interactome in Health and Disease
$390,185Jeffrey R Moore · University Of Massachusetts Lowell · R01 · FY2017 · HL
Ca2+ Influx-Mediated Damage and Regeneration of the Adult Myocardium
$390,152Steven R Houser · Temple Univ Of The Commonwealth · P01 · FY2012 · HL
Role of Adenosine Receptors in Cardiac Failure and Protection
$390,152Arthur M Feldman · Temple Univ Of The Commonwealth · P01 · FY2012 · HL
Novel Nuclear GRK5 Activity in the heart: Good or Bad?
$390,152Walter J Koch · Temple Univ Of The Commonwealth · P01 · FY2012 · HL
Targeted Cancer Therapeutics and Heart Failure: Mechanisms and Post-injury Repair
$390,151Thomas Force · Temple Univ Of The Commonwealth · P01 · FY2012 · HL
PKC alpha as a translational target in Heart Failure
$390,115Jeffery D Molkentin · Temple Univ Of The Commonwealth · P01 · FY2014 · HL
ERK Signaling and a Hybrid Surgical/Molecular Approach for Chronic Heart Failure
$390,100Michael J Mann · University Of California, San Francisco · R01 · FY2015 · HL
Human Cardiorenal Syndrome
$390,085Horng H Chen · Mayo Clinic Rochester · R01 · FY2016 · HL
Role of T-box genes in mouse development
$390,082Virginia E. Papaioannou · Columbia University Health Sciences · R37 · FY2008 · HD
Phenotype prediction and therapeutic targets in high-risk pediatric sepsis-associated MODS
$390,046Lazaro Nelson Sanchez-Pinto · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · HD
Formulation and pharmacokinetics of subcutaneous administration of deferiprone for prevention of chronic heart failure following hemorrhagic myocardial infarction.
$390,028Robert E Finney · Cardio-Theranostics Llc · R43 · FY2023 · HL
Targeting Adiponectin for Cardioprotection in the Ischemic Heart
$390,001Xin-Liang Ma · Thomas Jefferson University · R01 · FY2018 · HL
Dynamics of cardiac nuclei in heart disease
$390,000Thomas Martin Vondriska · University Of California Los Angeles · R01 · FY2023 · HL
Na+K+ATPase: Role of Alpha Isoforms
$390,000Jerry B Lingrel · University Of Cincinnati · R01 · FY2008 · HL
B-Arrestins and G Protein-Coupled Receptor Kinases in Cardiovascular Function
$390,000Robert J Lefkowitz · Duke University · R01 · FY2008 · HL
Molecular Mechanisms of Neural Crest-Related Heart Defects
$390,000Simon J Conway · Indiana University Indianapolis · R01 · FY2016 · HL
Identification of genetic modifiers of heart disease
$390,000Douglas A Marchuk · Duke University · R01 · FY2008 · HL
ER-associated protein Reticulon in atherosclerosis
$390,000Jun Yu · Temple Univ Of The Commonwealth · R01 · FY2016 · HL
Targeting Gbg-GRK2 signaling in fibrotic remodeling
$390,000Burns C Blaxall · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · HL
Integrated Crosstalk of Thin Filament Post-translational Modifications
$390,000Brandon J Biesiadecki · Ohio State University · R01 · FY2021 · HL
Inhibiting Cell Death for Protecting Cardiac Injury
$390,000Hua Zhu · Ohio State University · R01 · FY2023 · HL